TA
GNMX

Teachers Advisors’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Teachers Advisors’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-39,332
Closed -$73K – 3209
2017
Q1 		$73K Hold
39,332
– – ﹤0.01% 3015
2016
Q4 		$204K Hold
39,332
– – ﹤0.01% 2904
2016
Q3 		$219K Buy
39,332
+5,060
+15% +$28.8K ﹤0.01% 2853
2016
Q2 		$190K Buy
34,272
+3,774
+12% +$19.8K ﹤0.01% 2919
2016
Q1 		$134K Hold
30,498
– – ﹤0.01% 2899
2015
Q4 		$184K Buy
30,498
+5,574
+22% +$37.8K ﹤0.01% 2892
2015
Q3 		$195K Buy
24,924
+712
+3% +$5.52K ﹤0.01% 2881
2015
Q2 		$148K Buy
+24,212
New +$188K ﹤0.01% 3025

Other funds holding GNMX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Teachers Advisors's GNMX Position: Q2 2017 in Review

Teachers Advisors sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2017, closing a stake of 39,332 shares — an estimated $73K sold.

Teachers Advisors first reported a position in GNMX in Q2 2015 and held it in 8 quarters. The position peaked at $219K in Q3 2016. 51 funds tracked by Wall St. Rank hold GNMX as of Q2 2017.

  • Teachers Advisors reported no remaining Aevi Genomic Medicine Inc position as of Q2 2017 after selling out during the quarter.
  • Teachers Advisors sold 39,332 Aevi Genomic Medicine Inc shares in Q2 2017, an estimated $73K.
  • Teachers Advisors first reported a position in Aevi Genomic Medicine Inc in Q2 2015 and held it in 8 quarters.
  • Teachers Advisors's Aevi Genomic Medicine Inc position peaked at $219K in Q3 2016.
  • 51 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.